Literature DB >> 7819016

Development biology of the renal kallikrein-kinin system.

S S el-Dahr1.   

Abstract

Kinins are endothelium-dependent vasodilators and natriuretic paracrine peptides that participate in the regulation of blood pressure, renal hemodynamics and sodium excretion. Several lines of evidence suggest an important role for intrarenal kinins and their receptors in kidney growth and development. (1) The developing rat kidney expresses all the components of the tissue kallikrein-kinin system: tissue kallikrein, low molecular weight (LMW) kininogen, kininase II and kinin receptors. Also, the developing liver expresses high molecular weight and LMW kininogens. Thus, a complete kinin-generating system exists in the developing kidney. (2) Gene transcription, mRNA and protein abundance, and enzymatic activity of renal kallikrein are all markedly up-regulated during postnatal kidney growth, and a positive correlation exists between renal kallikrein synthesis and the maturational rise in renal blood flow. (3) Rat glomerular mesangial cells in culture express the kinin receptors and proliferate in response to bradykinin, suggesting that endogenous kinins and their receptors modulate glomerular growth. (4) The newborn period is characterized by an activation of kinin receptor gene expression, and chronic pharmacological blockade of kinin receptors suppresses DNA synthesis in the developing but not adult kidney. Collectively, these data provide the basis for the hypothesis that endogenous kinins and the kinin receptors play an important role in the developmental biology of the metanephric kidney.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7819016     DOI: 10.1007/bf00858150

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  73 in total

1.  Detection of low molecular kininogen messenger RNA in human kidney.

Authors:  N Iwai; M Matsunaga; T Kita; M Tei; C Kawai
Journal:  J Hypertens Suppl       Date:  1988-12

2.  Differential expression of the multiple forms of rat prekininogen mRNAs after acute inflammation.

Authors:  R Kageyama; N Kitamura; H Ohkubo; S Nakanishi
Journal:  J Biol Chem       Date:  1985-10-05       Impact factor: 5.157

3.  Characterization of receptor-mediated actions of T-kinin.

Authors:  X Gao; J M Stewart; R J Vavrek; L M Greenbaum
Journal:  Biochem Pharmacol       Date:  1993-11-02       Impact factor: 5.858

4.  Adrenal kallikrein.

Authors:  H Nolly; G Saed; O A Carretero; G Scicli; A G Scicli
Journal:  Hypertension       Date:  1993-06       Impact factor: 10.190

5.  Characterization and localization of human renal kininogen.

Authors:  D Proud; M Perkins; J V Pierce; K N Yates; P F Highet; P L Herring; M Mangkornkanok/Mark; R Bahu; F Carone; J J Pisano
Journal:  J Biol Chem       Date:  1981-10-25       Impact factor: 5.157

6.  Characterization of a B2-bradykinin receptor in rat renal mesangial cells.

Authors:  C Emond; J L Bascands; C Pecher; G Cabos-Boutot; P Pradelles; D Regoli; J P Girolami
Journal:  Eur J Pharmacol       Date:  1990-11-13       Impact factor: 4.432

7.  Effects of kinins on cultured arterial smooth muscle.

Authors:  B S Dixon; R Breckon; J Fortune; R J Vavrek; J M Stewart; R Marzec-Calvert; S L Linas
Journal:  Am J Physiol       Date:  1990-02

8.  Identification, purification, and localization of tissue kallikrein in rat heart.

Authors:  W Xiong; L M Chen; C Woodley-Miller; J A Simson; J Chao
Journal:  Biochem J       Date:  1990-05-01       Impact factor: 3.857

9.  Role of kinins and nitric oxide in the effects of angiotensin converting enzyme inhibitors on neointima formation.

Authors:  R D Farhy; O A Carretero; K L Ho; A G Scicli
Journal:  Circ Res       Date:  1993-06       Impact factor: 17.367

10.  Regulation of kininogen gene expression and localization in the lung after monocrotaline-induced pulmonary hypertension in rats.

Authors:  J Chao; J A Simson; P Chung; L M Chen; L Chao
Journal:  Proc Soc Exp Biol Med       Date:  1993-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.